^
BIOMARKER:

EML4-ALK + ALK G1202R + LIPI-NTRK1

i
Other names: NBLST3, CD246, Anaplastic Lymphoma Kinase, Anaplastic Lymphoma Kinase (Ki-1), CD246 Antigen, Mutant Anaplastic Lymphoma Kinase, ALK, ALK Receptor Tyrosine Kinase, Anaplastic Lymphoma Receptor Tyrosine Kinase, ALK Tyrosine Kinase Receptor, EML4, EMAP Like 4, Restrictedly Overexpressed Proliferation-Associated Protein, Echinoderm Microtubule-Associated Protein-Like 4, Echinoderm Microtubule Associated Protein Like 4, Ropp 120, C2orf2, EMAP-4, EMAPL4, ROPP120, ELP120, LIPI, Lipase I, Cancer/Testis Antigen 17, CT17, LPDL, Membrane-Associated Phosphatidic Acid-Selective Phospholipase A1-Beta, Lipase Member I, MPA-PLA1 Beta, LPD Lipase, PLA1C, PRED5, Membrane-Associated Phospholipase A1 Beta, MPA-PLA1beta, NTRK1, MTC, TRK, TRKA, Neurotrophic tyrosine kinase, receptor, type 1
Entrez ID:
News
Twitter
Trials
EML4-ALK + ALK G1202R + LIPI-NTRK1
LUAD
crizotinib
Sensitive: C4 – Case Studies
EML4-ALK + ALK G1202R + LIPI-NTRK1
LUAD
brigatinib
Resistant: C4 – Case Studies